Catherine Moukheibir - 05 Apr 2022 Form 3 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role: Director
Signature: /s/ Matthias Bodenstedt, Attorney-in-fact for Catherine Moukheibir
Issuer symbol: MLTX
Transactions as of: 05 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 15 Apr 2022, 16:06:15 UTC
Previous filing: 17 Mar 2022
Next filing: 05 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney